Basic information of Chen Tao.

Male, born in April, 1943, party member, researcher, doctoral supervisor. He is currently a member of the Academic Committee and Academic Degree Committee of Wuhan Institute of Virology, Chinese Academy of Sciences, China Academy of Sciences. 1July, 967, graduated from Nanjing Agricultural University majoring in plant protection, and was assigned to work in Wuhan Institute of Virology, Chinese Academy of Sciences, China Academy of Sciences. 197965438+served as an assistant researcher in February, 1990 1 month as an associate researcher and1996 as a researcher in September. During my work in the institute, I was mainly engaged in the research, production and application of microorganisms and their secondary metabolites and biopharmaceuticals; He has presided over more than 20 national, academy, provincial and ministerial scientific research projects, including 2 national natural science funds, 3 national key scientific and technological projects in the Eighth Five-Year Plan, the Ninth Five-Year Plan and the Tenth Five-Year Plan, the National New Drug Research Fund 1 and the provincial academy projects 14. He has published 64 papers and 4 books, and won 8 national, provincial, academy and municipal achievement awards. Since 1990, he has participated in many national seminars on biochemical drugs and natural medicines. Responsible for PLC project research for more than ten years, and basically completed its pharmacological research, anti-platelet function experiment and some toxicological experiments. The research results are jointly sponsored by the High-tech Industry Development Bureau of China Academy of Sciences, Shanghai Branch of Chinese Academy of Sciences and Shanghai Pudong New Area Science and Technology Bureau. Its achievements are at the international advanced level. In recent years, the high technology of producing β -carotene and polyunsaturated fatty acids by microbial fermentation has been successfully developed. The former has been put into production, and the latter is also in preparation. Has obtained three national patents. 1993 was granted a special allowance by the state government, and 1994 was awarded to a young and middle-aged expert with outstanding contributions in Hubei province. He presided over the major knowledge innovation project of China Academy of Sciences: preclinical research on a new drug-anti-platelet aggregation PLC, the National Natural Science Foundation: research on the anti-platelet aggregation mechanism of a new compound PLC, and the national key research project in the Tenth Five-Year Plan: screening, classification and application evaluation of high-yield PLC bacteria, and organized the implementation of the project.